GLYCOPHOS sol perf 20 amp 20 ml
7680527800012
CH-52780
B05XA14
07.01.2.
1 / 3
google
Details
- Product number
- 5278001
- CPT
- -
- Packaging group
- 20 x 20
- Unit
- ml
- Composition
- natrii glycerophosphas 216 mg ut natrii glycerophosphas pentahydricus corresp. phosphas 1 mmol et natrium 2 mmol, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
Glycophos, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
20 x 20
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
216.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
1.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Fresenius Kabi (Schweiz) AG
6010 Kriens
Authorization information
- Swissmedic authorization number
- 52780
- Drug name
- Glycophos, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- B05XA14
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 23/02/1995
- Authorization expiration date
- 31/12/9999
- IT number
- 07.01.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- GLYCOPHOS sol perf 20 amp 20 ml
- Description (DE)
- GLYCOPHOS Inf Lös 20 Amp 20 ml
- Market launch
- 23/02/1995
- Narcotic (BTM)
- No